Form 4: Vicarious Surgical Grants Options to President Sachs

Vicarious Surgical Inc. granted 38,675 stock options to President Adam David Sachs, vesting monthly over four years.

Summary

• Adam David Sachs, who serves as President, Director, and a 10% Owner of Vicarious Surgical Inc. (RBOT), was granted 38,675 stock options.
• The stock options have an exercise price of $7.61 per share.
• The options will vest in 48 equal monthly installments, commencing one month after the grant date, contingent upon Mr. Sachs' continued service to the company.
• The expiration date for these stock options is June 26, 2035.

Sentiment

Score: 6

Explanation: The filing reports a standard executive compensation event (stock option grant) which is generally viewed as a neutral to slightly positive development as it aligns management incentives with shareholder interests. It does not contain any unexpected positive or negative financial or operational news.

Positives

• Granting stock options to a key executive like the President aligns management's long-term interests with those of shareholders, incentivizing value creation.
• The 48-month vesting schedule encourages the executive's continued service and commitment to the company's sustained success.
• The specified exercise price of $7.61 provides a clear target for stock price appreciation, indicating the level at which the options become valuable.

Negatives

• No immediate negative implications are apparent from this routine executive compensation grant.

Risks

• The value of the stock options is contingent on Vicarious Surgical Inc.'s stock price exceeding the $7.61 exercise price; if the stock price remains below this level, the options may expire worthless.
• Vesting of the options is subject to Adam David Sachs' continued employment with the company, meaning unvested options could be forfeited upon departure.

Future Outlook

The 48-month vesting schedule for the stock options implies an expectation of continued service from the President and a long-term focus on the company's performance and growth.

Management Comments

• No direct quotes or paraphrased statements from company management are included in this Form 4 filing.

Industry Context

Granting stock options to key executives is a standard practice across various industries, particularly in technology and growth-oriented sectors, to attract, retain, and incentivize top talent by aligning their financial interests with shareholder value creation.

Comparison to Industry Standards

• The grant of stock options with a multi-year vesting schedule is a common executive compensation structure.
• While specific comparable companies or projects are not detailed in this filing, such grants are typical for executives in publicly traded medical technology or robotics companies, aiming to tie compensation to long-term stock performance.
• The exercise price and number of options would typically be benchmarked against peer companies of similar size and stage of development, but this filing does not provide such comparative data.

Management Changes

Corporate Governance

Legal Proceedings

• No legal proceedings or regulatory matters are mentioned in this filing.

Related Party Transactions

• The grant of stock options to Adam David Sachs, who is a Director, President, and 10% Owner, constitutes a related party transaction as it involves compensation to a key insider.

Stakeholder Impact

• Shareholders: Potential positive impact through enhanced alignment of executive incentives with long-term stock performance.
• Employees: Adam David Sachs, as an employee, benefits from the potential future value of the options. No direct impact on other employees is noted.

Next Steps

• Continued service of Adam David Sachs is required to facilitate the vesting of the granted stock options over the next 48 months.

Key Dates

Keywords

Vicarious Surgical Inc., RBOT, Stock Options, Executive Compensation, Insider Transaction, Form 4, Adam David Sachs, Director, President, Equity Grant, Vesting